(Q42010174)

15 October 2017

Tacrolimus (FK506)-Associated Renal Pathology (English)

1 reference

15 October 2017

2

Thomas E Starzl

1 reference

15 October 2017

Parmjeet S Randhawa

1

1 reference

PMC publication ID

3092646

15 October 2017

Anthony Jake Demetris

series ordinal

3

1 reference

15 October 2017

1 July 1997

1 reference

Advances in Anatomic Pathology

15 October 2017

1 reference

15 October 2017

4

1 reference

15 October 2017

4

1 reference

15 October 2017

265-276

1 reference

Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The differential diagnosis between rejection and cyclosporine toxicity.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Renal transplant morphology after long-term therapy with cyclosporine.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Adverse effects of FK 506 overdosage after liver transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK506-associated thrombotic thrombocytopenic purpura.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Tacrolimus: a new immunosuppressive agent.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

A prospective randomized trial of FK506-based immunosuppression after renal transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Randomised trialomania? The multicentre liver transplant trials of tacrolimus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Myocyte vacuolization in infarct border zones is reversible

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Cyclosporin and renal graft histology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Mannitol potentiates cyclosporine nephrotoxicity.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Chronic injury of human renal microvessels with low-dose cyclosporine therapy.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK 506 for liver, kidney, and pancreas transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Vascular effects of cyclosporine A in vivo and in vitro

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Histological changes in cardiac hemochromatosis improved by an iron-chelating agent. A biopsy case.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Cyclosporin-Associated Thrombotic Microangiopathy: Successful Retreatment with Cyclosporin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Disruption of renal function and gene expression by FK 506 and cyclosporine

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Pharmacokinetics of FK 506 in transplant patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

FK 506-induced nephrotoxicity in rats

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Liver, kidney, and thoracic organ transplantation under FK 506.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Kidney transplantation under FK 506

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The effect of FK 506 and CyA on the Lewis rat renal ischemia model

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

The effects of FK 506 on renal function after liver transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Clinical trial of FK 506 immunosuppression in adult cardiac transplantation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Induction of thromboses within renal grafts by high-dose prophylactic OKT3

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Effect of FK 506 on the expression of endothelin receptor mRNA in the vasculature.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092646

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

17 August 2018

1 reference

12 December 2020

Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis

1 reference

12 December 2020

Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine

1 reference

12 December 2020

Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts

1 reference

12 December 2020

Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies

1 reference

12 December 2020

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group

1 reference

12 December 2020

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model

1 reference

12 December 2020

Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop

1 reference

12 December 2020

Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation

1 reference

12 December 2020

Japanese study of FK 506 on kidney transplantation: results of an early phase II study. Japanese FK 506 Study Group

1 reference

12 December 2020

Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A

1 reference

12 December 2020

Ciclosporin-associated arteriolopathy: the renin producing vascular smooth muscle cells are more sensitive to ciclosporin toxicity

1 reference

12 December 2020

Hemodynamically mediated glomerular injury and the progressive nature of kidney disease

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group

1 reference

12 December 2020

Influence of cyclosporin A on the respiration of isolated rat kidney mitochondria

1 reference

12 December 2020

Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity

1 reference

12 December 2020

Toxicologic evaluation of FK 506

1 reference

12 December 2020

Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions

1 reference

12 December 2020

Segmental arterial mediolysis: a precursor to fibromuscular dysplasia?

1 reference

12 December 2020

Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Japanese FK 506 Study Group

1 reference

12 December 2020

The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients

1 reference

12 December 2020

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

12 December 2020

Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis

1 reference

12 December 2020

Cyclosporine A and intravascular coagulation

1 reference

12 December 2020

Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation

1 reference

12 December 2020

Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group

1 reference

12 December 2020

Clinical trial of tacrolimus versus cyclosporine in lung transplantation

1 reference

12 December 2020

Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin

1 reference

12 December 2020

Systemic toxicity associated with doxorubicin administration in cats

1 reference

12 December 2020

Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril

1 reference

12 December 2020

Efficacy of FK506 in renal transplantation

1 reference

12 December 2020

Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin

1 reference

12 December 2020

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival

1 reference

12 December 2020

Short-term FK 506-induced morphological changes in rat kidneys

1 reference

12 December 2020

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group

1 reference

12 December 2020

Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine

1 reference

12 December 2020

FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model

1 reference

12 December 2020

10.1097/00125480-199707000-00032

Identifiers

DOI

1 reference

15 October 2017

1 reference

PMC publication ID

3092646

15 October 2017

PubMed publication ID

21572890

1 reference

PMC publication ID

3092646